Drugs / Pneumococcal 7-valent Conjugate Vaccine
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial · 1 met primary | ||||||
| Phase 3 | NCT00474526 | Mar 2007 → Sep 2008 | meningococcal meningitis | Novartis Vaccines | Completed | Met primary |
| Phase not applicable1 trial | ||||||
| — | NCT00257127 | Feb → Aug 2006 | HIV infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Pneumococcal 7-valent Conjugate Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00474526 ↗ |
| Known as | PCV7 | “HIV-infected children 2-<19 years administered two doses of pneumococcal conjugate vaccine (PCV7) and one dose of polysaccharide vaccine (PPV) on HAART were randomized 4-5...” PMID 23954381 ↗ Aug 2013 |
| Modality | Vaccine | “Pneumococcal 7-valent conjugate vaccine” NCT00257127 ↗ |